Jung Sun Ahn

Title: Innovations by Jung Sun Ahn

Introduction

Jung Sun Ahn is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of virology, particularly in the development of binding molecules for neutralizing viruses. With a total of 2 patents, Ahn's work is pivotal in advancing vaccine efficacy and immune response.

Latest Patents

Ahn's latest patents include two groundbreaking inventions. The first patent focuses on a rabies virus G protein epitope and a rabies-virus-neutralizing binding molecule that binds specifically to it. This invention identifies different epitope sites of the rabies virus G protein and develops binding molecules that retain neutralizing activity against various rabies viruses. The second patent pertains to an adjuvant composition containing at least one influenza virus neutralizing and binding molecule, along with a vaccine composition that incorporates this adjuvant. This composition enhances the effects of vaccines and is crucial for preventing diseases caused by viruses.

Career Highlights

Jung Sun Ahn is currently associated with Celltrion Inc., a leading biopharmaceutical company. His work at Celltrion has allowed him to focus on innovative solutions in vaccine development and viral neutralization.

Collaborations

Ahn collaborates with talented individuals such as Shin Jae Chang and Soo Young Lee, who contribute to his research endeavors. Their combined expertise fosters a productive environment for innovation.

Conclusion

Jung Sun Ahn's contributions to virology through his patents and collaborations highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also has practical implications for public health.